A cell‐type resolved proton RBE model for potential clinical application
Medical Physics · 2026-11 · 53 (11)
DOI: 10.1002/mp.70743 ↗At a glance
Journal article in Medical Physics, published online on 2026-10-30. Written by Yinghui Li and 5 co-authors. Institution: School of Biomedical Engineering, Capital Medical University, Beijing, China. Major MEDLINE topics: Relative Biological Effectiveness, Proton Therapy, Models, Biological. 20 references. Funded by: Chinese institutes for Medical Research.
Abstract (original language)
Background
Despite decades of effort, researchers have failed to develop a clinically implementable Relative Biological Effectiveness (RBE) model that can improve dose accuracy in proton therapy. A key challenge is that RBE's dependence on cell‐type is not well understood. This study aimed to overcome this challenge.
Methods
A total of 139 eligible experimental datasets covering 33 cell lines from the Particle Irradiation Data Ensemble (PIDE) database were used in this study. A Poisson‐based cell survival model, which has two new parameters α and β conceptually different from that in the conventional LQ model, was used to derive a proton RBE model by globally fitting the proton experimental data. The two parameters’ fitting values for a cell's photon data, α X and β X , were used to characterize the cell type. RBE's dependence on cell type was investigated by studying RBE variation on α X and β X .
Results
The Poisson‐based model showed better global fitting than the LQ model (RMSE w = 6.4% vs. 7.8%, p = 0.00003). A comprehensive RBE model expressed as RBE (LET, D P , α X , β X ) was consequently derived. Interestingly, RBE appears to vary minimally within 95% CI of α X variation, while vary greatly for β X variation. Cells were divided into two groups according to β X , and the comprehensive model was simplified into a cell‐type resolved model by establishing two cell‐type‐independent models for the two groups, respectively. This cell‐type resolved model shows better agreement with experimental data than the comprehensive model derived from the LQ model.
Conclusion
The variation of β X , which represents a cell's repair capability for critical damages, mainly contributes to RBE's cell‐type dependence. A cell‐type resolved model agreeing well with experimental data has been established.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- School of Biomedical Engineering, Capital Medical University, Beijing, China.
- Varian Medical Systems, Advanced Oncology Solutions, Lancaster, Ohio, USA.
- Department of Clinical Oncology, Hong Kong University Shenzhen Hospital, Shenzhen, China.
- Department of Clinical Oncology, Queen Mary Hospital, Li Ka Shing Medical School, The University of Hong Kong, Hong Kong, China.
- Beijing Chest Hospital, Capital Medical University, Beijing, China.
Funding
- Chinese institutes for Medical Research
Cite
APA
Li, Y., Qin, X., Yuan, J. K., You, P., Spring Kong, F. M., & Jin, J. Y. (2026). A cell‐type resolved proton RBE model for potential clinical application. Medical Physics, 53(11). https://doi.org/10.1002/mp.70743
Vancouver
Li Y, Qin X, Yuan JK, You P, Spring Kong FM, Jin JY. A cell‐type resolved proton RBE model for potential clinical application. Medical Physics. 2026;53(11). doi:10.1002/mp.70743
BibTeX
@article{Li2026,
author = {Li, Yinghui and Qin, Xiaohang and Yuan, Jian-Kui and You, Peimeng and Spring Kong, Feng-Ming and Jin, Jian-Yue},
title = {A cell‐type resolved proton RBE model for potential clinical application},
journal = {Medical Physics},
year = {2026},
volume = {53},
number = {11},
doi = {10.1002/mp.70743}
}
EUVIMED